ARTICLE | Clinical News
NanGenex preclinical data
August 2, 2010 7:00 AM UTC
In rats and beagles, oral administration of the NanoActive nanoformulation of 3 undisclosed angiotensin II receptor antagonists marketed to treat hypertension displayed significantly increased bioavai...